SLAYBACK PHARMA
Slayback is founded on the principle of “connecting the dots”. This principle translates into their philosophy of connecting one idea with another. The idea is to conceptualize and develop complex generic and specialty drugs. They focus on products that are challenging and highly complex to develop and/or manufacture. It could be a complex oil-in-water emulsion or a sterile long acting injectable using nano-spheres or sterile suspensions with complex particle physics. They have also worked o... n complex hormonal products with challenging cross-contamination issues. They aim to optimize the use of technology and potential (generated from a strong experience in this field) to develop a value proposition for their customers. Through this process of drug development, they remotely aim at reducing the cost of therapy by bringing expensive branded drugs within the reach of patients.
SLAYBACK PHARMA
Social Links:
Industry:
Biopharma Manufacturing Pharmaceutical
Founded:
2011-01-01
Address:
Princeton, New Jersey, United States
Country:
United States
Website Url:
http://www.slayback-pharma.com
Total Employee:
101+
Status:
Active
Contact:
609-945-3443
Email Addresses:
[email protected]
Total Funding:
110 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Apache
Similar Organizations
BioQ Pharma
BioQ Pharma is a late stage specialty pharmaceutical company focused on developing.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
EOC Pharma Group
EOC Pharma is an integrated biopharmaceutical company.
MAIA Pharmaceuticals
MAIA Pharmaceuticals identifies, develops, manufactures and markets innovative and niche generic products.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Reviva Pharmaceuticals
Reviva Pharmaceuticals is a clinical-stage pharmaceutical company developing innovative therapies.
Silk Therapeutics
Silk Therapeutics is a biotech company that offers skincare products for human health and wellness.
Theravance Biopharma
Theravance Biopharma is a biopharmaceutical company with one approved product.
Xenon Pharmaceuticals
Xenon Pharmaceuticals operates as a neurology-focused biopharmaceutical company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Everstone
Everstone investment in Series B - Slayback Pharma
Kohlberg Kravis Roberts
Kohlberg Kravis Roberts investment in Private Equity Round - Slayback Pharma
Official Site Inspections
http://www.slayback-pharma.com Semrush global rank: 4.87 M Semrush visits lastest month: 1.81 K
- Host name: ip17.ip-192-95-16.net
- IP address: 192.95.16.17
- Location: Newark United States
- Latitude: 40.7265
- Longitude: -74.1782
- Metro Code: 501
- Timezone: America/New_York
- Postal: 07102
More informations about "Slayback Pharma"
Azurity Pharmaceuticals Acquires Slayback Pharma
Sep 27, 2023 MEDIA ALERT: WOBURN, MA, September 27, 2023 – Azurity Pharmaceuticals, Inc. (“Azurity”) is pleased to announce the closing of its acquisition of Slayback Pharma LLC (“Slayback”) today from existing investors …See details»
Slayback Pharma - Overview, News & Similar companies - ZoomInfo
Apr 26, 2023 Who is Slayback Pharma. Slayback is a New-Jersey based pharmaceutical company focused on the development of complex generic and specialty pharmaceutical …See details»
Slayback Pharma - LinkedIn
Slayback Pharma LLC is a specialty pharmaceutical company focused on developing, manufacturing and sourcing of complex generic pharmaceutical products, with a specific emphasis on complex ...See details»
Slayback Pharma Company Profile | Management and Employees …
Slayback Pharma Profile and History. Slayback is a New-Jersey based pharmaceutical company focused on the development of complex generic and specialty pharmaceutical products with a …See details»
Azurity Pharmaceuticals acquires Slayback Pharma - 2023-09-27 ...
Slayback Pharma Slayback Pharma believe every pharmaceutical product exhibits its own unique personality. Acquiring Organization: Azurity Pharmaceuticals Azurity Pharmaceuticals is a …See details»
Azurity Pharmaceuticals Acquires Slayback Pharma - PR …
WOBURN, Ma., Sept. 27, 2023 /PRNewswire/ -- Azurity Pharmaceuticals, Inc. ("Azurity") is pleased to announce the closing of its acquisition of Slayback Pharma LLC ("Slayback") today from existing ...See details»
Slayback Pharma - Company Profile and News - Bloomberg Markets
Slayback Pharma Limited Liability Company manufactures generic and specialty pharmaceutical products. The Company offers propofol injectable emulsion injections with research and …See details»
Slayback Pharma - Products, Competitors, Financials, Employees ...
Slayback Pharma is a specialty pharmaceutical company operating in the healthcare sector. The company focuses on the development, manufacturing, and sourcing of complex generic …See details»
Slayback Pharma Company Profile - Office Locations, Competitors …
Slayback Pharma Summary. Company Summary. Overview. Slayback Pharma is a pharmaceutical company focused on developing, manufacturing, and sourcing of complex …See details»
Slayback Pharma - PitchBook
Slayback Pharma General Information Description. Manufacturer of pharmaceutical products focused on complex injectables and other non-solid oral products. The company engages in …See details»
About Us – Slayback-Pharma
Slayback is a New Jersey-based company focused on complex generic and specialty pharmaceutical products with a team of 85 employees and operations in the U.S., India and …See details»
Azurity Pharmaceuticals Acquires Slayback Pharma
Sep 27, 2023 Azurity Pharmaceuticals, Inc. announced the closing of its acquisition of Slayback Pharma LLC today from its existing investors. Slayback is now a wholly-owned subsidiary of …See details»
Azurity Pharmaceuticals Acquires Slayback Pharma
Sep 27, 2023 Azurity Pharmaceuticals, Inc. is pleased to announce the closing of its acquisition of Slayback Pharma LLC today from existing investors including KKR, a leading global …See details»
Azurity Pharmaceuticals Acquires Slayback Pharma
Oct 3, 2023 Slayback’s R&D capabilities and innovative dose forms will complement Azurity’s commercial expertise. Azurity Pharmaceuticals, Inc. (“Azurity”) is pleased to announce the …See details»
Slayback Pharma - Funding, Financials, Valuation & Investors
Private Equity Round - Slayback Pharma . 1: obfuscated. obfuscated. Kohlberg Kravis Roberts: Investors. Edit Investors Section. Number of Lead Investors 2. Number of Investors 2. …See details»
Azurity Pharmaceuticals Acquires KKR-backed Slayback Pharma
Sep 28, 2023 WOBURN, MA – Azurity Pharmaceuticals, Inc. (“Azurity”) is pleased to announce the closing of its acquisition of Slayback Pharma LLC (“Slayback”) today from existing …See details»
Slayback Pharma: Revenue, Competitors, Alternatives - Growjo
Slayback Pharma LLC is a specialty pharmaceutical company focused on developing, manufacturing and sourcing of complex generic pharmaceutical products, with a specific …See details»
Slayback Pharma - Contacts, Employees, Board Members
Slayback Pharma has 3 current employee profiles, including Vice President of Operations Gyan Ranjan. Slayback Pharma has 4 board members and advisors, including Neel Varshney. …See details»
Endo Announces Agreement with Slayback Pharma to Distribute
Apr 26, 2023 About Slayback Pharma LLC Slayback is a New-Jersey based pharmaceutical company focused on the development and commercialization of complex generic and …See details»